AN2 Therapeutics Inc (ANTX) Stock Price

1.185 ▲ +0.005 (+0.42%)
Open: 1.22 Vol: 0 Day's range: 1.185 - 1.22 Jan 21, 15:59 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ANTX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 1.20▼ 1.20▼ 1.20▼ 1.23▼ 1.19▼
MA10 1.20▼ 1.23▼ 1.23▼ 1.22▼ 1.15▲
MA20 1.23▼ 1.25▼ 1.24▼ 1.17▲ 1.19▼
MA50 1.26▼ 1.23▼ 1.20▼ 1.14▲ 1.18▲
MA100 1.19▼ 1.18▲ 1.18▲ 1.19▼ 1.50▼
MA200 1.17▲ 1.15▲ 1.15▲ 1.17▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.003▼ -0.012▼ -0.014▼ 0.002▲ 0.010▲
RSI 40.992▼ 41.136▼ 42.619▼ 50.961▲ 50.007▲
STOCH 45.040     10.284▼ 10.284▼ 61.225     50.724    
WILL %R -92.857▼ -96.667▼ -96.667▼ -47.128     -48.611    
CCI -86.822     -87.256     -87.256     9.852     44.671    
Latest Filters Detected On ANTX
▲ MA $ANTX MA(20) Crossed Above MA(200) Set Alert
▲ GAP $ANTX Open Gap Up %3 Set Alert
▲ GAP $ANTX Open Gap Up %2 Set Alert
CDL $ANTX Matching Low Candlestick Pattern Detected Set Alert
AN2 Therapeutics Inc News
AN2 Therapeutics Announces FDA Clearance to Proceed with 90-Patient Investigator-Initiated Trial (IIT) of Epetraborole in Patients with M. abscessus Lung Disease
Monday, January 12, 2026 03:00 AM
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics derived from its boron chemistry platform, today announced that the U.S. Food and Drug ...
AN2 Therapeutics to Participate in Fireside Chat at Evercore HealthCONx Conference
Thursday, November 06, 2025 06:03 AM
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced ...
AN2 Therapeutics Commences First-in-Human Clinical Trial of Oral AN2-502998 for Chagas Disease
Tuesday, August 12, 2025 04:01 AM
Preclinical studies in nonhuman primates naturally infected with T. cruzi have shown AN2-502998's curative potential in chronic Chagas disease No FDA approved treatment for adults with Chagas disease ...
ANTX historical stock data
date open high low close volume
21/01/26 1.22 1.22 1.185 1.185 70,380
20/01/26 1.23 1.23 1.145 1.18 105,758
16/01/26 1.27 1.27 1.20 1.20 21,936
15/01/26 1.31 1.3488 1.25 1.25 25,001
14/01/26 1.27 1.3488 1.2205 1.31 116,281
13/01/26 1.13 1.28 1.13 1.26 100,929
12/01/26 1.31 1.3385 1.14 1.14 173,058
09/01/26 1.32 1.34 1.29 1.30 83,041
08/01/26 1.10 1.3499 1.08 1.32 1,058,625
07/01/26 1.08 1.12 1.075 1.10 68,770
Quote Details
52wk Low:1.00
52wk High:1.55
Vol:0
Avg Vol(3m):1.6M
1Y Chng:+7.73%
1M Chng:+7.73%
Add to Watch List
More Information
Index US Composite
Market Cap. 32.88M